Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Long-Term Investments (2016 - 2026)

Biomerica's Long-Term Investments history spans 16 years, with the latest figure at $165000.0 for Q1 2026.

  • Quarterly results put Long-Term Investments at $165000.0 for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Feb 2026 was $165000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $165000.0, changed 0.0%.
  • Long-Term Investments for Q1 2026 was $165000.0 at Biomerica, roughly flat from $165000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $165324.0 in Q1 2022 to a low of $165000.0 in Q2 2022.
  • The 5-year median for Long-Term Investments is $165000.0 (2022), against an average of $165076.2.
  • Peak annual rise in Long-Term Investments hit 0.0% in 2022, while the deepest fall reached 0.2% in 2022.
  • Year by year, Long-Term Investments stood at $165324.0 in 2022, then decreased by 0.2% to $165000.0 in 2023, then changed by 0.0% to $165000.0 in 2024, then changed by 0.0% to $165000.0 in 2025, then changed by 0.0% to $165000.0 in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $165000.0, $165000.0, and $165000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.